ClearPoint Neuro Inc vs Nvidia Corp — how do they compare? ClearPoint Neuro Inc trades at $15.7 (market cap $478.63M), while Nvidia Corp trades at $210.97 (market cap $5.13T). The key difference: Nvidia Corp is far larger — about 10718.1× ClearPoint Neuro Inc's market cap, and Nvidia Corp pays a 0.47% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | NVDA | |
|---|---|---|
Market Cap | $478.63M | $5.13T |
Sector | Health | Technology |
52-Week High | $29.60 | $235.75 |
52-Week Low | $8.66 | $165.17 |
Enterprise Value | $506.63M | $5.06T |
Dividend Yield | — | 0.47% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVIDIA (NVDA) trades at $203.53, down 3.52% on the day, with a bullish technical outlook supported by moving averages and key support at $201. The company reported strong revenue growth to $130.50B in 2025, with net income surging to $72.88B and a robust net margin of 55.84%. Recent earnings beats and a consensus analyst price target of $325.86 highlight strong fundamental momentum amid AI-driven demand.
Outlook remains positive with AI infrastructure expansion driving growth, though risks include increased competition and market volatility. Wall Street sentiment is bullish with 75% buy ratings, but investors should monitor execution risks and macroeconomic headwinds that could impact valuation multiples.
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →